These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 6116855)

  • 21. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants.
    Coulehan JL; Hallowell C; Michaels RH; Welty TK; Lui N; Kuo JS
    J Infect Dis; 1983 Sep; 148(3):530-4. PubMed ID: 6311913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age.
    King SD; Ramlal A; Wynter H; Moodie K; Castle D; Kuo JS; Barnes L; Williams CL
    Lancet; 1981 Oct; 2(8249):705-9. PubMed ID: 6116855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Haemophilus influenzae type b vaccines.
    Stieb DM; Frayha HH; Oxman AD; Shannon HS; Hutchison BG; Crombie FS
    CMAJ; 1990 Apr; 142(7):719-33. PubMed ID: 2107962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
    Anderson PW; Stein EC; Insel RA
    Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal vaccination: work to date and future prospects.
    Musher DM; Watson DA; Dominguez EA
    Am J Med Sci; 1990 Jul; 300(1):45-52. PubMed ID: 2196794
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.